Magkos Faidon

Faidon Magkos

Appointment(s)
  • Assistant Professor, Department of Physiology
Joint Appointment(s)
  • Principal Investigator, Clinical Nutrition Research Centre, A*STAR
Academic Qualifications
  • Post-Doc,┬áHarvard Medical School, USA
  • PhD, Harokopio University, Greece
  • PhD, Washington University School of Medicine, USA
  • BSc, MSc, Harokopio University, Greece
Research Interest(s)
  • Mechanisms
  • Effects of Diet
  • Nutrition
Recent Publications
  • 1. Magkos F, Patterson BW, Mohammed BS, Mittendorfer B. 2007 Jun. A single 1-h bout of evening exercise increases basal FFA flux without affecting VLDL-triglyceride and VLDL-apolipoprotein B-100 kinetics in untrained lean men. Am J Physiol Endocrinol Metab. 292(6):E1568-74. doi: 10.1152/ajpendo.00636.2006. 17264219.
  • 2. Fabbrini E, Magkos F, Mohammed BS, Pietka T, Abumrad NA, Patterson BW, Okunade A, Klein S. 2009 Sep. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci USA. 8;106(36):15430-5. doi: 10.1073/pnas.0904944106. 19706383.
  • 3. Magkos F, Su X, Bradley D, Fabbrini E, Conte C, Eagon JC, Varela JE, Brunt EM, Patterson BW, Klein S. 2012 Jun. Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects. Gastroenterology. 142(7):1444-6e2. doi: 10.1053/j.gastro.2012.03.003. 22425588.
  • 4. Magkos F, Fabbrini E, Conte C, Patterson BW, Klein S. 2012 Jul. Relationship between adipose tissue lipolytic activity and skeletal muscle insulin resistance in nondiabetic women. J Clin Endocrinol Metab. 97(7):E1219-23. doi: 10.1210/jc.2012-1035. 22492868.
  • 5. Fabbrini E, Yoshino J, Yoshino M, Magkos F, Tiemann Luecking C, Samovski D, Fraterrigo G, Okunade AL, Patterson BW, Klein S. 2015 Feb. Metabolically normal obese people are protected from adverse effects following weight gain. J Clin Invest. 125(2):787-95. doi: 10.1172/JCI78425. 25555214.